Nari GA, López-Ben S, Mariot D, Albiol M, Góngora-Ortega J, Figueras J

Language: Spanish
References: 35
Page: 528-533
PDF size: 188.60 Kb.

ABSTRACT

Introduction: Between 20 and 40% of liver metastases from colorectal tumor are synchronous. Three types of surgical approaches are proposed; two of them propose a deferred resection and the other, simultaneous resection. The aim of this analysis is to assess the short- and long-term outcomes of simultaneous resections. Method: 212 synchronous liver metastases resected in two centers were evaluated. Comparison between those resected simultaneously with those that were in a deferred way was made. Demographics, liver resections and metastatic characteristics were evaluated. Morbidity and mortality of both alternatives are also evaluated. Results: 63 patients were resected simultaneously with the primary tumor, there were no significant differences in demographic characteristics. There was a greater number of major resections (p = 0.005) in the deferred group. Morbidity and mortality was comparable in both groups. Liver failure (p = 0.037) was higher in the deferred group. Morbidity was 33.2% in the deferred and 10.1% for the simultaneous (p = 0.256). Mortality rate was 2.83% in the deferred and 0.94% in the simultaneous group (p = 0.508). Conclusion: Short and long-term outcomes for both groups are similar. A question remains to be answered: the need of a major hepatectomy will favor the election of a deferred treatment?

REFERENCES

1. Nari G, Moreno E, Feliu L, Azar R, Bonaparte F. Resecciones hepáticas sin tecnología de punta. Ocho años de experiencia. Rev Colomb Cir. 2011;26:48-55.

2. Yin Z, Liu Ch, Chen Y, Bai Y, Shang Ch, Yin R, et al. Timing of hepatectomy in resectable synchronous colo-rectal liver metastases (SCRLM): simultaneous or delayes. Hepatology. 2013;57:2346-57.

3. Yoshioka R, Hasegawa K, Mise Y, Oba M, Aoki T, Sakamoto Y, et al. Evaluation of safety and efficacy of simultaneous resection of primary colorectal cancer and synchronous liver metastases. Surgery. 2014; 155:478-85.

4. Reddy S, Pawlik T, Zorzi D, Gleisner A, Ribero D, Assumpcao L, et al. Simultaneous resection of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol. 2007;14:381-91.

5. Minagawa M, Yamamoto J, Miwa S, Sakamoto Y, Kokudo N, Kosuge T, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg. 2006;141:1006-12.

6. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg. 1982;6:3-9.

7. González H, Figueras J. Practical questions in liver metastases of colorectal cancer: general principles of treatment. HPB. 2007;9:251-8.

8. Makuuchi M, Takayasu K, Takuma Y. Preoperative trans-catheter embolization of the portal venous branch for patients receiving extended lobectomy due to bile duct carcinoma. J Jpn Surg Assoc. 1984;45:1558-64.

9. Stolz A, Gagniere J, Dupre M, Rivoire M. Destruction locoregionale des metastases hepatiques d’origine colorectale. Place de la radiofrequence. Journal de Chirurgie Viscerale. 2014;151:534-46.

10. De Santibañes E, Clavien J. Playing play-doh to prevent postoperative liver failure. The “ALPPS” approach. Ann Surg. 2012;255:415-7.

11. Grundmann R. Current state of surgical treatment of liver metastases from colorectal cancer. Word J Gastrointest Surg. 2011;27:183-96.

12. Fahy B, Fischer C. Syncronous resection of colorectal primary and hepatic mestastasis. J Gastrointest Oncol. 2012;3:48-58.

13. Mayo S, Pulitano C, Marques H, Lamelas J, Wolfgang C, de Saussure W, et al. Surgical management of patients with synchronous colorectal liver matastases: a multicenter international analysis. J Am Coll Surg. 2013; 216:707-18.

14. Vauthey J, Pawlik T, Ribero D, Wu T, Zorzi D, Hoff P, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90 day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065-72.

15. Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giachetti S, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxiplatin in colorectal cancer liver metastases. J Clin Oncol. 2006;24:4983-90.

16. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al. Influence of chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1-7.

17. Strasberg S, Phillips C. Use and dissemination of the Brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg. 2013;257:377-82.

18. Dindo D, Demartines N, Clavien P. Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of survey. Ann Surg. 2004;240:205-13.

19. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The 50-50 criteria on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824-8.

20. Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andrés A, et al. Liver first approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg. 2008;25:430-5.

21. Martin RC 2nd, Augenstein V, Reuter N, Scoggins C, Mc Masters K. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg. 2009;208:842-50.

22. Martin R, Paty P, Fong Y, Grace A, Cohen A, De Matteo R, et al. Simultaneous liver and colorectal resection are safe for synchronous colorectal liver metastases. J Am Coll Surg. 2003;197:23-41.

23. Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Sekido H, et al. Outcom after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery. 2004;136:650-9.

24. Weber J, Bachellier P, Oussoultzoglou E, Jaek D. Simultaneous resection of colorectal primary tumour and syncronic liver metastases. Br J Surg. 2003;90:956-62.

25. Turrini O, Viret F, Guiramand J, Lelong B, Bege T, Delpiero J. Strategies for the treatment of synchronous liver metastasis. Eur J Surg Oncol. 2007;33:735-40.

26. Luo Y, Wang L, Chen C, Chen D, Huang M, Huang Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases. J Gastrointest Surg. 2010;14:1974-80.

27. Abbot D, Cantor S, Hu C, Aloia T, You Y, Nguyen S, et al. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg. 2012;215:262-70.

28. Thelen A, Jonas S, Benckert C, Spinelli A, Lopez-Hänninen E, Rudolph B, et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis. 2007; 22(10):1269-76.

29. Bolton J, Fuhrman G. Survival after resection of multiple bilobar metastases from colorectal carcinoma. Ann Surg. 2000;231:743-51.

30. Capussotti L, Ferrero A, Vigano L. Timing of resection of liver metastases synchronous with colorectal surgery. Ann Surg Oncol. 2007;14:195-201.

31. De Santibañes E, Lasalle F, Mc Cormack L. Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and long-term outcomes. J Am Coll Surg. 2002;195:196-202.

32. Lykoudis P, O’Reilly D, Nastos K, Fussi G. Systematic review of surgical management of synchronous colorectal liver metastases. BJS. 2014; 101:605-12.

33. Nari G, Palacios O, López Ben S, Albiol M, Falgueras L, Castro Gutiérrez E, et al. Hilar cholangiocarcinoma: the number of positive nodes and positive node/total node ratio is a significant prognostic factor for survival. Cir Esp. 2014;92:247-53.

34. Karoui M, Vigano L, Goyer P, Ferrero A, Luciani A, Aglietta M, et al. Combined first stage hepatectomy and colorectal resection in a two stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg. 2010;97:1354-62.

35. Andres A, Mentha G, Adam R, Gerstel E, Skipenko O, Barroso E, et al. Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases. BJS. 2015;102:691-9.